#1005, Duke Cancer Institute is a clinical research site located in Durham, North Carolina, United States 27710.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
#1005, Duke Cancer Institute has participated in 1 clinical trials.
Therapeutic areas: Advanced Solid Tumor.
Sponsors: Repare Therapeutics.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
#1005, Duke Cancer Institute has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
#1005, Duke Cancer Institute has 1 clinical trials on record. Their work covers Advanced Solid Tumor.
#1005, Duke Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.